There are 2934 resources available
Proffered Paper 1 – Gastrointestinal tumours, colorectal - Invited Discussant LBA30_PR and 522O
Presenter: Clara Montagut Viladot
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Slides
Proffered Paper – Haematological malignancies & pediatric oncology - Invited Discussant 1065O and 1066O
Presenter: Anastasios Stathis
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Slides
Webcast
Has molecular classification changed the surgical approach in endometrial cancer?
Presenter: Christian Marth
Session: Treating endometrial cancer in the molecular age
Resources:
Slides
Webcast
3837 - PD-L1 expression, patterns of progression and patient-reported outcomes (PROs) with durvalumab plus platinum-etoposide in ES-SCLC: Results from CASPIAN
Presenter: Luis Paz-Ares
Session: Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC)
Resources:
Abstract
Slides
Webcast
4627 - Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)
Presenter: Antonio González Martín
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
3955 - Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev
Presenter: Isabelle Ray-Coquard
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
2772 - VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC)
Presenter: Robert Coleman
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
7128 - Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 Part 1 final analysis
Presenter: Solange Peters
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
567 - Osimertinib vs comparator EGFR-TKI as first-line treatment for EGFRm advanced NSCLC (FLAURA): Final overall survival analysis
Presenter: Suresh Ramalingam
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
Mutation directed therapy for ER + breast cancer
Presenter: Matthew Ellis
Session: Challenges in the management of luminal ER + MBC
Resources:
Slides
Webcast